IRIS
BRAVACCINI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.388
AS - Asia 985
EU - Europa 698
SA - Sud America 324
AF - Africa 16
OC - Oceania 2
Totale 3.413
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.348
SG - Singapore 444
HK - Hong Kong 389
IE - Irlanda 311
BR - Brasile 304
DE - Germania 88
IT - Italia 84
TR - Turchia 54
FR - Francia 41
NL - Olanda 32
GB - Regno Unito 29
FI - Finlandia 25
CA - Canada 23
IN - India 21
RU - Federazione Russa 20
BD - Bangladesh 19
MX - Messico 14
AT - Austria 13
VN - Vietnam 13
IQ - Iraq 12
LT - Lituania 11
AR - Argentina 7
ES - Italia 7
PL - Polonia 7
BE - Belgio 6
CZ - Repubblica Ceca 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
CN - Cina 5
CO - Colombia 5
JP - Giappone 5
SA - Arabia Saudita 5
SE - Svezia 5
TN - Tunisia 5
UA - Ucraina 5
PK - Pakistan 4
VE - Venezuela 4
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
EC - Ecuador 2
KG - Kirghizistan 2
RS - Serbia 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
MA - Marocco 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 3.413
Salva come PNG Salva come JPEG
Città #
Dallas 691
Hong Kong 387
Dublin 311
Singapore 203
Santa Clara 137
Boardman 131
The Dalles 88
Istanbul 43
Munich 38
Ashburn 35
Assago 32
São Paulo 28
Amsterdam 23
Helsinki 22
Los Angeles 18
Frankfurt am Main 16
Boston 10
Chicago 10
Milan 10
Belo Horizonte 9
Düsseldorf 9
Montreal 9
New York 9
San Francisco 9
Vienna 9
Brasília 8
Rio de Janeiro 8
Brooklyn 7
Ankara 6
Brno 6
Brussels 6
Mexico City 6
Paris 6
Toronto 6
Atlanta 5
Bexley 5
Campinas 5
Chennai 5
Ho Chi Minh City 5
Lugo 5
Stockholm 5
Tashkent 5
Tokyo 5
Warsaw 5
Bogotá 4
Guarulhos 4
Juiz de Fora 4
New Delhi 4
Nuremberg 4
Ottawa 4
Porto Alegre 4
Riyadh 4
Rome 4
Betim 3
Birmingham 3
Houston 3
Lauterbourg 3
Limeira 3
London 3
Manchester 3
Maricá 3
Milwaukee 3
Palhoça 3
Pescara 3
Portsmouth 3
Ribeirão Preto 3
Roubaix 3
Santo André 3
São Sebastião do Paraíso 3
Turku 3
Viamão 3
Virginia Beach 3
Americana 2
Apodi 2
Atibaia 2
Avaré 2
Baku 2
Basra 2
Belgrade 2
Bishkek 2
Cape Town 2
Caxias do Sul 2
Charlotte 2
Cincinnati 2
Contagem 2
Curitiba 2
Dakar 2
Delhi 2
Denver 2
Fortaleza 2
Garanhuns 2
Hortolândia 2
Itajubá 2
Itapema 2
Itaquaquecetuba 2
Johannesburg 2
João Pessoa 2
Lecce 2
Misilmeri 2
Nova Iguaçu 2
Totale 2.545
Salva come PNG Salva come JPEG
Nome #
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients? 77
Biomarkers: which ones do we really need today? 55
The use of platelets as a clinical tool in oncology: opportunities and challenges 52
Re: Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer 46
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study 45
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution 41
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy. 37
Androgen receptor signaling pathways as a target for breast cancer treatment 37
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota 36
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension 36
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer 36
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter 35
Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa 35
TMB in NSCLC: A Broken Dream? 35
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in patients with different subtypes of breast cancer 35
A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors 35
Urinary Biomarkers in Tumors: An Overview 35
Expanding the Horizon of Multidisciplinarity: Incorporating Biomechanical, Metabolic, and Functional Factors Into Registry-Based Research to Predict Subsequent Risk for Total Knee Arthroplasty 34
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer 34
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment? 34
Telomerase Activity Analysis In Urine Sediment for Bladder Cancer 34
Are we ready to use TMB in breast cancer clinical practice? 33
An H-1 NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 33
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 Severity 32
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? 32
Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study 32
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? 32
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience 31
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 31
An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection 31
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance 31
Androgen receptor in breast cancer: The "5W" questions 31
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study 30
Letter to the Editor discussing: Hacker S, Lenz C, Reichert L, Ringseis R, Zentgraf K, Krüger K. Vitamin D status and its determinants in German elite athletes. Eur J Appl Physiol. 2025 Jan 4. doi: 10.1007/s00421-024–05699-6 30
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design 30
Expanding Roles of De Novo Lipogenesis in Breast Cancer 29
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 29
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement 29
NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus 28
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data 28
Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer 28
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients 28
Urinary biomarkers of nonmuscle-invasive bladder cancer: current status and future potential 28
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer 28
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer 28
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? 28
Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer 28
Usefulness of immunological detection of the human telomerase reverse transcriptase 27
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma insitu treated with surgery and radiotherapy 27
Relevance of urine telomerase in the diagnosis of bladder cancer 27
Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit) 27
Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells 26
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer? 26
What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia? 26
ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA 26
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease. 26
Why the complications of COVID-19 patients differ in elderly and young cancer patients 26
Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR) 25
Urine telomerase: An important marker in the diagnosis of bladder cancer 25
Combined analysis of miR-200 family and its significance for breast cancer 25
International consensus on severe lung cancer-the first edition 25
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? 25
Sorafenib for the treatment of breast cancer 25
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 25
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer 24
Setting Up a Medical Oncology Educational Program in Sub-Saharan Africa 24
Spotlight on PSMA as a new theranostic biomarker for bladder cancer 24
What to look for in cell-free DNA from breast cancer patients 24
In-111-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance 24
The current role of telomerase in the diagnosis of bladder cancer 24
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country 24
CAR T cells targeting options in the fight against multiple myeloma 24
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold 24
Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression 24
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 24
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis 23
Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling 23
Molecular characterization of cytotoxic and drug resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines 23
Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT) 23
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy 23
The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study 23
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects 22
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls 22
Frequency of Actionable Alterations in EGFR wt NSCLC: Experience of the Wide Catchment Area of Romagna (AVR) 22
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue 22
Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer? 22
Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer 22
Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitro 22
Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer" 22
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer? 22
Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer A case report 21
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization 21
Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients 21
Biofunctional characteristics of in situ and invasive breast carcinoma 21
Unraveling the protein kinase C/NDRG1 signaling network in breast cancer. 21
Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy 21
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN 21
Knee pain and gait alterations: bridging physiology, biomechanics, and clinical practice 21
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report 20
FAP inhibitors: are we really using the best method to evaluate the residence time? 20
Totale 2.869
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024187 0 0 0 0 0 0 0 0 0 0 0 187
2024/20252.496 264 71 193 57 234 318 149 135 304 299 283 189
2025/2026986 313 673 0 0 0 0 0 0 0 0 0 0
Totale 3.669